Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An innovative clinical-stage oncology company is seeking a Scientist II in Biology to drive research initiatives in a dynamic lab environment. This role involves executing experiments, leading drug discovery projects, and developing bioassays to support groundbreaking cancer therapies. The ideal candidate will have a Ph.D. or MSc with significant experience in molecular biology and cancer research. Join a forward-thinking organization dedicated to precision medicine and make a meaningful impact in the fight against cancer. This is a unique opportunity to contribute to the development of next-generation radioconjugates and work alongside a talented team in a collaborative setting.
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to targeting molecules to deliver payloads to tumors. Our portfolio includes FPI-2265, FPI-1434, and FPI-2068, with ongoing clinical trials, and we are pursuing combination programs with DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. We operate a GMP-compliant radiopharmaceutical manufacturing facility to support our pipeline.
We are seeking a Scientist II, Biology, to contribute to our research initiatives. This lab-based role is located in Hamilton, Ontario, Canada.
Fusion is an equal opportunity employer committed to inclusive recruitment. If you require accommodations during the interview process, please inform Human Resources. All qualified applicants will be considered without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or veteran status.